Previous Section
Clinical Trials
71. Elevated plasma tissue inhibitor of metalloproteinase-1 level predicts decreased response and survival in metastatic breast cancer.
- Author
- Lipton A; Ali SM; Leitzel K; Demers L; Evans DB; Hamer P; Brown-Shimer S; Pierce K; Carney W;
- Institution
- Department of Hematology-Oncology, Penn State University, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033, USA.
- Journal
- Cancer. 2007 May 15;109(10):1933-9.
- Abstract URL
- Click here to view abstract
72. Randomized controlled trial comparing a low-fat diet with a weight-reduction diet in breast cancer-related lymphedema.
- Author
- Shaw C; Mortimer P; Judd PA; Shaw C; Mortimer P; Judd PA;
- Institution
- Royal Marsden NHS Foundation Trust, London, UK. clare.shaw@rmh.nhs.uk
- Journal
- Cancer. 2007 May 15;109(10):1949-56.
- Abstract URL
- Click here to view abstract
73. Benefits of supervised group exercise programme for women being treated for early stage breast cancer: pragmatic randomised controlled trial.
- Author
- Mutrie N; Campbell AM; Whyte F; McConnachie A; Emslie C; Lee L; Kearney N; Walker A; Ritchie D;
- Institution
- Department of Sport, Culture and the Arts, Strathclyde University, Glasgow G13 1PP. nanette.mutrie@strath.ac.uk
- Journal
- BMJ. 2007 Mar 10;334(7592):517. Epub 2007 Feb 16.
- Abstract URL
- Click here to view abstract
74. Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial.
- Author
- Coombes RC; Kilburn LS; Snowdon CF; Paridaens R; Coleman RE; Jones SE; Jassem J; Van de Velde CJ; Delozier T; Alvarez I; Del Mastro L; Ortmann O; Diedrich K; Coates AS; Bajetta E; Holmberg SB; Dodwell D; Mickiewicz E; Andersen J; Lonning PE; Cocconi G; Forbes J; Castiglione M; Stuart N; Stewart A; Fallowfield LJ; Bertelli G; Hall E; Bogle RG; Carpentieri M; Colajori E; Subar M; Ireland E; Bliss JM;
- Institution
- Cancer Research UK Department of Cancer Medicine, Division of Surgery, Oncology, Reproductive Biology and Anaesthetics, Imperial College London, Faculty of Medicine, Hammersmith Hospitals Trust, London W12 0NN, UK.
- Journal
- Lancet. 2007 Feb 17;369(9561):559-70.
- Abstract URL
- Click here to view abstract
75. Phase II Study of Neoadjuvant Docetaxel, Vinorelbine, and Trastuzumab Followed by Surgery and Adjuvant Doxorubicin Plus Cyclophosphamide in Women With Human Epidermal Growth Factor Receptor 2-Overexpressing Locally Advanced Breast Cancer.
- Author
- Limentani SA; Brufsky AM; Erban JK; Jahanzeb M; Lewis D;
- Institution
- Carolinas Hematology-Oncology Associates; The Blumenthal Cancer Center, Charlotte, NC; Department of Medicine, Division of Hematology-Oncology, University of Pittsburgh Magee-Womens Hospital, Pittsburgh, PA; Department of Medicine, Tufts-New England Medical Center, Boston, MA; and Division of Hematology-Oncology, University of Tennessee College of Medicine, Memphis, TN.
- Journal
- J Clin Oncol. 2007 Feb 12;.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
